Carcinoma ; complications ; Carcinoma, Papillary ; Female ; Histiocytosis, Langerhans-Cell ; complications ; Humans ; Middle Aged ; Thyroid Neoplasms ; complications

Carcinoma ; complications ; Carcinoma, Papillary ; Female ; Humans ; Middle Aged ; Thyroid Neoplasms ; complications ; Tuberculosis, Lymph Node ; complications

Carcinoma ; complications ; therapy ; Cholangitis ; complications ; therapy ; Drainage ; Humans ; Semicircular Ducts

Adult ; Carcinoma ; complications ; Female ; Humans ; Kidney Neoplasms ; complications ; Solitary Fibrous Tumors ; complications ; Thyroid Neoplasms ; complications

Carcinoma, Renal Cell ; complications ; Guillain-Barre Syndrome ; complications ; Humans ; Kidney Neoplasms ; complications ; Meningeal Neoplasms ; complications ; Meningioma ; complications

We describe a 58-years-old man with a primary nasopharyngeal carcinoma accompanying erythroderma. His first symptoms were systemic scattered erythema and itching for six months. Lower right cervical lymphadenectasis was found by physical examination. A neoplasm in nasopharynx could be seen with nasal endoscope. The pathology of the neoplasm was non-keratinizing carcinoma. This case illustrates that "erythroderma" could be a paraneoplastic effect of nasopharyngeal carcinoma.
Carcinoma ; Dermatitis, Exfoliative ; complications ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms ; complications ; Paraneoplastic Endocrine Syndromes ; complications

Carcinoma ; Humans ; Male ; Meningeal Neoplasms ; complications ; Meningioma ; complications ; Middle Aged ; Nasopharyngeal Neoplasms ; complications

Aged ; Carcinoma, Renal Cell ; complications ; Eosinophilia ; complications ; Humans ; Kidney Neoplasms ; complications ; Male ; Paraneoplastic Syndromes

Carcinoma, Renal Cell ; complications ; Humans ; Kidney Neoplasms ; complications ; Lymphoma, Non-Hodgkin ; complications ; Male ; Middle Aged

Metabolic (dysfunction) associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is the most common cause of chronic liver disease worldwide. Many risk factors contribute to the pathogenesis of MAFLD with metabolic dysregulation being the final arbiter of its development and progression. MAFLD poses a substantial economic burden to societies, which based on current trends is expected to increase over time. Numerous studies have addressed various aspects of MAFLD from its risk associations to its economic and social burden and clinical diagnosis and management, as well as the molecular mechanisms linking MAFLD to end-stage liver disease and hepatocellular carcinoma. This review summarizes current understanding of the pathogenesis of MAFLD and related diseases, particularly liver cancer. Potential therapeutic agents for MAFLD and diagnostic biomarkers are discussed.
Carcinoma, Hepatocellular/complications* ; Humans ; Liver Neoplasms/complications* ; Non-alcoholic Fatty Liver Disease/complications* ; Risk Factors